nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—ADRB2—chronic obstructive pulmonary disease	0.252	1	CbGaD
Penbutolol—Nadolol—Salbutamol—chronic obstructive pulmonary disease	0.1	0.269	CrCrCtD
Penbutolol—Levobunolol—Salbutamol—chronic obstructive pulmonary disease	0.1	0.269	CrCrCtD
Penbutolol—Carteolol—Salbutamol—chronic obstructive pulmonary disease	0.1	0.269	CrCrCtD
Penbutolol—Bupranolol—Salbutamol—chronic obstructive pulmonary disease	0.0724	0.194	CrCrCtD
Penbutolol—ADRB2—Salbutamol—chronic obstructive pulmonary disease	0.0702	0.2	CbGbCtD
Penbutolol—ADRB1—Salbutamol—chronic obstructive pulmonary disease	0.0692	0.197	CbGbCtD
Penbutolol—ADRB2—Formoterol—chronic obstructive pulmonary disease	0.0532	0.152	CbGbCtD
Penbutolol—ADRB2—Arformoterol—chronic obstructive pulmonary disease	0.0532	0.152	CbGbCtD
Penbutolol—ADRB1—Arformoterol—chronic obstructive pulmonary disease	0.0524	0.15	CbGbCtD
Penbutolol—ADRB1—Formoterol—chronic obstructive pulmonary disease	0.0524	0.15	CbGbCtD
Penbutolol—Depression—Roflumilast—chronic obstructive pulmonary disease	0.000601	0.0296	CcSEcCtD
Penbutolol—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.000583	0.0287	CcSEcCtD
Penbutolol—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.000564	0.0277	CcSEcCtD
Penbutolol—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.000564	0.0277	CcSEcCtD
Penbutolol—Levobunolol—ADRB2—chronic obstructive pulmonary disease	0.000456	0.163	CrCbGaD
Penbutolol—Timolol—ADRB2—chronic obstructive pulmonary disease	0.000435	0.155	CrCbGaD
Penbutolol—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.000435	0.0214	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.000395	0.0194	CcSEcCtD
Penbutolol—Carteolol—ADRB2—chronic obstructive pulmonary disease	0.000388	0.138	CrCbGaD
Penbutolol—Affect lability—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.0182	CcSEcCtD
Penbutolol—Mood swings—Salbutamol—chronic obstructive pulmonary disease	0.000355	0.0175	CcSEcCtD
Penbutolol—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000348	0.0171	CcSEcCtD
Penbutolol—Nadolol—ADRB2—chronic obstructive pulmonary disease	0.000346	0.123	CrCbGaD
Penbutolol—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.000338	0.0166	CcSEcCtD
Penbutolol—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000331	0.0163	CcSEcCtD
Penbutolol—Bupranolol—ADRB2—chronic obstructive pulmonary disease	0.00033	0.118	CrCbGaD
Penbutolol—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.0157	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.000319	0.0157	CcSEcCtD
Penbutolol—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000319	0.0157	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.000312	0.0154	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.0148	CcSEcCtD
Penbutolol—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.0136	CcSEcCtD
Penbutolol—Oxprenolol—ADRB2—chronic obstructive pulmonary disease	0.000276	0.0986	CrCbGaD
Penbutolol—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000276	0.0136	CcSEcCtD
Penbutolol—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000263	0.0129	CcSEcCtD
Penbutolol—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000259	0.0127	CcSEcCtD
Penbutolol—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000254	0.0125	CcSEcCtD
Penbutolol—Alprenolol—ADRB2—chronic obstructive pulmonary disease	0.000253	0.0902	CrCbGaD
Penbutolol—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000241	0.0118	CcSEcCtD
Penbutolol—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.0114	CcSEcCtD
Penbutolol—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000228	0.0112	CcSEcCtD
Penbutolol—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000226	0.0111	CcSEcCtD
Penbutolol—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.0108	CcSEcCtD
Penbutolol—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000213	0.0105	CcSEcCtD
Penbutolol—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.0104	CcSEcCtD
Penbutolol—Cough—Formoterol—chronic obstructive pulmonary disease	0.000209	0.0103	CcSEcCtD
Penbutolol—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.0103	CcSEcCtD
Penbutolol—Cough—Montelukast—chronic obstructive pulmonary disease	0.000204	0.0101	CcSEcCtD
Penbutolol—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000204	0.01	CcSEcCtD
Penbutolol—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000203	0.00997	CcSEcCtD
Penbutolol—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.00969	CcSEcCtD
Penbutolol—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000178	0.00876	CcSEcCtD
Penbutolol—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.00868	CcSEcCtD
Penbutolol—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000176	0.00868	CcSEcCtD
Penbutolol—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000175	0.00863	CcSEcCtD
Penbutolol—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00856	CcSEcCtD
Penbutolol—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00856	CcSEcCtD
Penbutolol—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000173	0.0085	CcSEcCtD
Penbutolol—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000172	0.00845	CcSEcCtD
Penbutolol—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000172	0.00845	CcSEcCtD
Penbutolol—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00017	0.00834	CcSEcCtD
Penbutolol—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000168	0.00828	CcSEcCtD
Penbutolol—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00828	CcSEcCtD
Penbutolol—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00828	CcSEcCtD
Penbutolol—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.00821	CcSEcCtD
Penbutolol—Pain—Formoterol—chronic obstructive pulmonary disease	0.000167	0.00821	CcSEcCtD
Penbutolol—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.0082	CcSEcCtD
Penbutolol—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00818	CcSEcCtD
Penbutolol—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00811	CcSEcCtD
Penbutolol—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00808	CcSEcCtD
Penbutolol—Pain—Montelukast—chronic obstructive pulmonary disease	0.000163	0.00804	CcSEcCtD
Penbutolol—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00798	CcSEcCtD
Penbutolol—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.0079	CcSEcCtD
Penbutolol—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00016	0.00787	CcSEcCtD
Penbutolol—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00781	CcSEcCtD
Penbutolol—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00775	CcSEcCtD
Penbutolol—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00759	CcSEcCtD
Penbutolol—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00759	CcSEcCtD
Penbutolol—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000154	0.00757	CcSEcCtD
Penbutolol—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000152	0.00749	CcSEcCtD
Penbutolol—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00745	CcSEcCtD
Penbutolol—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00745	CcSEcCtD
Penbutolol—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00743	CcSEcCtD
Penbutolol—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000148	0.00728	CcSEcCtD
Penbutolol—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00716	CcSEcCtD
Penbutolol—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000144	0.00706	CcSEcCtD
Penbutolol—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00014	0.00689	CcSEcCtD
Penbutolol—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00014	0.00689	CcSEcCtD
Penbutolol—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000137	0.00675	CcSEcCtD
Penbutolol—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000134	0.00657	CcSEcCtD
Penbutolol—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000134	0.00657	CcSEcCtD
Penbutolol—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000132	0.0065	CcSEcCtD
Penbutolol—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000131	0.00643	CcSEcCtD
Penbutolol—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000129	0.00635	CcSEcCtD
Penbutolol—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.00635	CcSEcCtD
Penbutolol—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00622	CcSEcCtD
Penbutolol—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000126	0.0062	CcSEcCtD
Penbutolol—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00612	CcSEcCtD
Penbutolol—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00601	CcSEcCtD
Penbutolol—Headache—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00601	CcSEcCtD
Penbutolol—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.00599	CcSEcCtD
Penbutolol—Depression—Prednisone—chronic obstructive pulmonary disease	0.00012	0.00591	CcSEcCtD
Penbutolol—Headache—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00589	CcSEcCtD
Penbutolol—Propranolol—ADRB2—chronic obstructive pulmonary disease	0.000119	0.0423	CrCbGaD
Penbutolol—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.0057	CcSEcCtD
Penbutolol—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000116	0.0057	CcSEcCtD
Penbutolol—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00568	CcSEcCtD
Penbutolol—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000114	0.00558	CcSEcCtD
Penbutolol—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00541	CcSEcCtD
Penbutolol—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000109	0.00538	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000102	0.00503	CcSEcCtD
Penbutolol—Propranolol—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.0363	CrCbGaD
Penbutolol—Propranolol—CYP1A2—chronic obstructive pulmonary disease	9.81e-05	0.035	CrCbGaD
Penbutolol—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.56e-05	0.0047	CcSEcCtD
Penbutolol—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.55e-05	0.0047	CcSEcCtD
Penbutolol—ADRB1—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	9.5e-05	0.0635	CbGpPWpGaD
Penbutolol—Pain—Prednisolone—chronic obstructive pulmonary disease	9.04e-05	0.00445	CcSEcCtD
Penbutolol—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	7.42e-05	0.00365	CcSEcCtD
Penbutolol—HTR1B—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	7.41e-05	0.0495	CbGpPWpGaD
Penbutolol—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.99e-05	0.00344	CcSEcCtD
Penbutolol—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.95e-05	0.00342	CcSEcCtD
Penbutolol—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.76e-05	0.00333	CcSEcCtD
Penbutolol—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.00326	CcSEcCtD
Penbutolol—Headache—Prednisolone—chronic obstructive pulmonary disease	6.62e-05	0.00326	CcSEcCtD
Penbutolol—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.28e-05	0.00309	CcSEcCtD
Penbutolol—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.00299	CcSEcCtD
Penbutolol—HTR1A—Serotonin receptors—HTR2A—chronic obstructive pulmonary disease	5.64e-05	0.0377	CbGpPWpGaD
Penbutolol—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.00271	CcSEcCtD
Penbutolol—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.25e-05	0.00258	CcSEcCtD
Penbutolol—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.08e-05	0.0025	CcSEcCtD
Penbutolol—Headache—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.00237	CcSEcCtD
Penbutolol—Nausea—Prednisone—chronic obstructive pulmonary disease	4.56e-05	0.00224	CcSEcCtD
Penbutolol—ADRB1—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	4.29e-05	0.0287	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	4.22e-05	0.0282	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	3.55e-05	0.0237	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	3.36e-05	0.0225	CbGpPWpGaD
Penbutolol—ADRB1—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	3.33e-05	0.0223	CbGpPWpGaD
Penbutolol—HTR1B—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	3.3e-05	0.022	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	3.21e-05	0.0215	CbGpPWpGaD
Penbutolol—ADRB1—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	3.12e-05	0.0209	CbGpPWpGaD
Penbutolol—ADRB1—Endothelin Pathways—EDN1—chronic obstructive pulmonary disease	3e-05	0.0201	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	2.82e-05	0.0189	CbGpPWpGaD
Penbutolol—HTR1B—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	2.77e-05	0.0185	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	2.7e-05	0.0181	CbGpPWpGaD
Penbutolol—ADRB1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	2.63e-05	0.0176	CbGpPWpGaD
Penbutolol—ADRB2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	2.57e-05	0.0172	CbGpPWpGaD
Penbutolol—HTR1A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	2.51e-05	0.0168	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	2.33e-05	0.0156	CbGpPWpGaD
Penbutolol—ADRB1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	2.3e-05	0.0154	CbGpPWpGaD
Penbutolol—ADRB2—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	2.25e-05	0.0151	CbGpPWpGaD
Penbutolol—ADRB1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	2.21e-05	0.0148	CbGpPWpGaD
Penbutolol—ADRB2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	2.16e-05	0.0144	CbGpPWpGaD
Penbutolol—HTR1A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	2.11e-05	0.0141	CbGpPWpGaD
Penbutolol—ADRB1—Endothelin Pathways—NOS3—chronic obstructive pulmonary disease	1.83e-05	0.0122	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	1.4e-05	0.00935	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	1.31e-05	0.00875	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	1.3e-05	0.00867	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	1.18e-05	0.0079	CbGpPWpGaD
Penbutolol—ADRB1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	1.16e-05	0.00779	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	1.14e-05	0.00763	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	1.11e-05	0.00743	CbGpPWpGaD
Penbutolol—ADRB2—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	1.11e-05	0.0074	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	1.06e-05	0.00712	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	1.03e-05	0.00691	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	1.01e-05	0.00676	CbGpPWpGaD
Penbutolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	1.01e-05	0.00672	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	9.88e-06	0.00661	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.85e-06	0.00592	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.66e-06	0.00579	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	8.47e-06	0.00566	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	8.46e-06	0.00566	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.19e-06	0.00548	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	8.14e-06	0.00544	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.25e-06	0.00485	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	6.97e-06	0.00466	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	6.93e-06	0.00464	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.74e-06	0.00451	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.59e-06	0.00441	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.48e-06	0.00433	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	6.45e-06	0.00431	CbGpPWpGaD
Penbutolol—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	6.36e-06	0.00425	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	6.23e-06	0.00417	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	6.2e-06	0.00415	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	5.93e-06	0.00397	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.55e-06	0.00371	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.52e-06	0.00369	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	5.45e-06	0.00364	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.4e-06	0.00361	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	5.39e-06	0.0036	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	5.31e-06	0.00355	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	5.31e-06	0.00355	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	5.28e-06	0.00353	CbGpPWpGaD
Penbutolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	5.07e-06	0.00339	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.96e-06	0.00332	CbGpPWpGaD
Penbutolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.96e-06	0.00331	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.85e-06	0.00325	CbGpPWpGaD
Penbutolol—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	4.85e-06	0.00324	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	4.78e-06	0.0032	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	4.75e-06	0.00317	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	4.75e-06	0.00317	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.73e-06	0.00316	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.62e-06	0.00309	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	4.52e-06	0.00302	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.48e-06	0.00299	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	4.34e-06	0.0029	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.34e-06	0.0029	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.3e-06	0.00287	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.29e-06	0.00287	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.25e-06	0.00284	CbGpPWpGaD
Penbutolol—HTR1B—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	4.24e-06	0.00283	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.23e-06	0.00283	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.2e-06	0.00281	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.2e-06	0.00281	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	4.15e-06	0.00278	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.15e-06	0.00278	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	4.11e-06	0.00274	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	4.05e-06	0.0027	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.81e-06	0.00255	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.78e-06	0.00253	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.73e-06	0.00249	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.7e-06	0.00247	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	3.64e-06	0.00244	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.64e-06	0.00243	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	3.61e-06	0.00242	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.46e-06	0.00231	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.38e-06	0.00226	CbGpPWpGaD
Penbutolol—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.37e-06	0.00225	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.35e-06	0.00224	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	3.31e-06	0.00221	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.31e-06	0.00221	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.27e-06	0.00219	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.23e-06	0.00216	CbGpPWpGaD
Penbutolol—HTR1A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	3.23e-06	0.00216	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.2e-06	0.00214	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.18e-06	0.00213	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	3.16e-06	0.00211	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.12e-06	0.00208	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	3e-06	0.00201	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.72e-06	0.00182	CbGpPWpGaD
Penbutolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.68e-06	0.00179	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.68e-06	0.00179	CbGpPWpGaD
Penbutolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.62e-06	0.00175	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.57e-06	0.00172	CbGpPWpGaD
Penbutolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	2.57e-06	0.00172	CbGpPWpGaD
Penbutolol—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.56e-06	0.00171	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.54e-06	0.0017	CbGpPWpGaD
Penbutolol—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.52e-06	0.00168	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.48e-06	0.00166	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.44e-06	0.00163	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.43e-06	0.00162	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.39e-06	0.0016	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.35e-06	0.00157	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.29e-06	0.00153	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.17e-06	0.00145	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.14e-06	0.00143	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.13e-06	0.00142	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.09e-06	0.0014	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.08e-06	0.00139	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.04e-06	0.00137	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.04e-06	0.00137	CbGpPWpGaD
Penbutolol—ADRB1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.04e-06	0.00137	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2e-06	0.00134	CbGpPWpGaD
Penbutolol—ADRB2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2e-06	0.00134	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.95e-06	0.00131	CbGpPWpGaD
Penbutolol—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.95e-06	0.00131	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.94e-06	0.0013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.9e-06	0.00127	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.88e-06	0.00125	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.87e-06	0.00125	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.86e-06	0.00124	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.83e-06	0.00122	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.79e-06	0.00119	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.74e-06	0.00117	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.7e-06	0.00113	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.66e-06	0.00111	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.62e-06	0.00109	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.61e-06	0.00108	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.49e-06	0.000999	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.46e-06	0.000977	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.45e-06	0.000969	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.44e-06	0.000962	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.43e-06	0.000956	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.39e-06	0.000929	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.36e-06	0.000909	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.33e-06	0.000888	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.32e-06	0.00088	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.31e-06	0.000874	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.28e-06	0.000857	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.26e-06	0.000841	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.23e-06	0.00082	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.17e-06	0.000782	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.15e-06	0.000772	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.15e-06	0.000766	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.13e-06	0.000755	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.12e-06	0.000749	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.1e-06	0.000738	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.1e-06	0.000733	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.05e-06	0.000701	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.04e-06	0.000696	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.03e-06	0.000686	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.02e-06	0.000681	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1e-06	0.00067	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1e-06	0.00067	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.96e-07	0.000666	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.8e-07	0.000656	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.62e-07	0.000643	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.59e-07	0.000641	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.32e-07	0.000623	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.18e-07	0.000614	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	9.11e-07	0.000609	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.91e-07	0.000596	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.76e-07	0.000586	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.77e-07	0.00052	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.66e-07	0.000512	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.49e-07	0.000501	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.39e-07	0.000494	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.33e-07	0.00049	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.31e-07	0.000489	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.15e-07	0.000478	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.03e-07	0.00047	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.99e-07	0.000468	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.98e-07	0.000467	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.83e-07	0.000457	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.68e-07	0.000446	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.31e-07	0.000422	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.19e-07	0.000414	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.06e-07	0.000405	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.92e-07	0.000396	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.89e-07	0.000394	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.8e-07	0.000388	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.76e-07	0.000385	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.68e-07	0.00038	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.63e-07	0.000377	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.6e-07	0.000374	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.48e-07	0.000366	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.36e-07	0.000358	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.03e-07	0.000336	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.92e-07	0.000329	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.81e-07	0.000322	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.77e-07	0.000319	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.62e-07	0.000309	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.53e-07	0.000303	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.52e-07	0.000302	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.43e-07	0.000296	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.41e-07	0.000295	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.37e-07	0.000292	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.33e-07	0.000289	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.8e-07	0.000254	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.72e-07	0.000249	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.63e-07	0.000243	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.48e-07	0.000233	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.4e-07	0.000227	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.33e-07	0.000222	CbGpPWpGaD
